1. Home
  2. MBINM vs IDYA Comparison

MBINM vs IDYA Comparison

Compare MBINM & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merchants Bancorp

MBINM

Merchants Bancorp

HOLD

Current Price

$25.51

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$33.57

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBINM
IDYA
Founded
N/A
2015
Country
United States
United States
Employees
663
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MBINM
IDYA
Price
$25.51
$33.57
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$49.18
AVG Volume (30 Days)
N/A
950.6K
Earning Date
N/A
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$214,834,000.00
Revenue This Year
N/A
$2,662.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5377.66
52 Week Low
N/A
$13.45
52 Week High
N/A
$37.08

Technical Indicators

Market Signals
Indicator
MBINM
IDYA
Relative Strength Index (RSI) 58.32 46.28
Support Level $25.45 $34.04
Resistance Level $25.96 $35.28
Average True Range (ATR) 0.26 1.07
MACD 0.01 -0.18
Stochastic Oscillator 63.49 14.14

Price Performance

Historical Comparison
MBINM
IDYA

About MBINM Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: